Nkarta, Inc. (NKTX) Misses Q1 EPS by 2c May 12, 2026 05:14PM
Nkarta gets FDA approval for outpatient dosing of autoimmune therapy Apr 15, 2026 04:01PM
Nkarta Inc. (NKTX) PT Lowered to $12 at Mizuho Mar 30, 2026 08:56AM
Nkarta (NKTX) Reiterated at Buy by Stifel; Estimates Largely Unchanged Mar 26, 2026 07:19AM
Nkarta, Inc. (NKTX) Misses Q4 EPS by 6c Mar 25, 2026 05:04PM


Nov 11, 2025 04:57AM Nkarta Inc. (NKTX) PT Lowered to $11 at Stifel
Nov 10, 2025 04:03PM Nkarta, Inc. (NKTX) Tops Q3 EPS by 1c
Oct 22, 2025 10:08AM Nkarta to present NK cell therapy data at rheumatology meeting
Aug 12, 2025 05:54PM Nkarta, Inc. (NKTX) Tops Q2 EPS by 4c
Jun 10, 2025 06:34AM Nkarta Inc. (NKTX) PT Lowered to $14 at Mizuho
May 15, 2025 04:00AM William Blair Downgrades Nkarta Inc. (NKTX) to Market Perform
May 14, 2025 04:11PM Nkarta, Inc. (NKTX) Tops Q1 EPS by 2c, provides guidance
Mar 27, 2025 07:45AM Nkarta Inc. (NKTX) PT Lowered to $14 at Stifel
Mar 27, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on Nkarta Inc. (NKTX)
Mar 27, 2025 05:11AM Nkarta Inc. (NKTX) PT Lowered to $14 at Stifel
Mar 26, 2025 04:18PM Nkarta (NKTX) to cut 34% staff
Nov 7, 2024 04:04PM Nkarta, Inc. (NKTX) Misses Q3 EPS by 2c, provides guidance
Aug 19, 2024 06:43AM Nkarta Inc. (NKTX) PT Lowered to $20 at Mizuho
Aug 14, 2024 06:42AM Nkarta Inc. (NKTX) PT Lowered to $22 at H.C. Wainwright
Aug 14, 2024 03:44AM Raymond James Upgrades Nkarta Inc. (NKTX) to Strong Buy
Aug 13, 2024 05:43PM Nkarta, Inc. (NKTX) Tops Q2 EPS by 13c
Jul 24, 2024 06:00AM Nkarta (NKTX) Initiates Investigator-Sponsored Clinical Trial of NKX019
Jul 16, 2024 06:01AM Nkarta (NKTX) Appoints Nadir Mahmood as President
Jun 28, 2024 06:41AM H.C. Wainwright Reiterates Buy Rating on Nkarta Inc. (NKTX)
Jun 27, 2024 06:01AM Nkarta (NKTX) Initiates Clinical Trial of NKX019
Jun 13, 2024 04:02PM Nkarta (NKTX) Appoints George Vratsanos to its Board